Pulmonary Hypertension Linked to Mortality After Atrial Septal Defect Repair
Persistent pulmonary hypertension is strong predictor of mortality in older patients who underwent ASD closure.
Pulmonary Hypertension
Balloon Pulmonary Angioplasty Effective for Chronic Thromboembolic PH
For patients with inoperable or residual postendarterectomy chronic thromboembolic pulmonary hypertension, performing a balloon pulmonary angioplasty provided improvements in pressure measurements, functional class, and exercise capacity with an acceptable risk profile.
Sotatercept Receives Orphan Drug Status for Pulmonary Arterial Hypertension
The FDA has granted Orphan Drug designation to sotatercept for the treatment of patients with pulmonary arterial hypertension.
New Pulmonary Hypertension Definition Clarifies Mortality Risk After Heart Transplant
Although an independent association was not identified between pulmonary vascular resistance and conditional 1-year mortality, it was identified between pulmonary vascular resistance and 30-day mortality.
Ralinepag Reduces Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension
Treatment with the next-generation potent prostacyclin receptor agonist ralinepag reduced pulmonary vascular resistance compared with placebo in patients with symptomatic pulmonary arterial hypertension.
Clinical Case: Dyspnea on Exertion After Complications From Chemotherapy
A 65-year-old woman with breast cancer and hypertension has been experiencing progressive dyspnea on exertion after complications from chemotherapy.
Effects of Pulmonary Hypertension on Outcomes After MVR for Rheumatic Mitral Stenosis
Researchers gauged the effect of concomitant pulmonary hypertension on clinical outcomes and late-onset progression of tricuspid regurgitation after mitral valve relapse for rheumatic mitral stenosis.
Pulmonary Arterial Hypertension in Women: New Approaches to Care
Investigators provide recent information on the classification, pathophysiology, diagnosis, and treatment of pulmonary arterial hypertension, focusing specifically on its impact on women.
Exercise Tolerance in PAH Increased With Thrice-Daily Oral Treprostinil
This pharmacokinetic substudy was conducted to determine the actual pharmacokinetic profiles of treprostinil in patients transitioning from stable twice daily to stable thrice daily dosing regimens.
Implantable Hemodynamic Sensor May Guide Therapy in PAH With Right-Sided HF
An implantable hemodynamic monitor safely monitored hemodynamic changes in patients with severe pulmonary arterial hypertension.
Next post in Pulmonary Vasculature
